LeonaBio (LONA) Accumulated Expenses (2019 - 2026)

LeonaBio (LONA) has 8 years of Accumulated Expenses data on file, last reported at $1.2 million in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $1.2 million, down 70.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (down 70.99% YoY), and the FY2025 annual result was $5.0 million, down 59.98% from the prior year.
• Accumulated Expenses fell to $1.2 million in Q1 2026 per LONA's latest filing, from $5.0 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $17.0 million in Q3 2024 and troughed at $1.2 million in Q1 2026.
• A 5-year average of $7.4 million and a median of $9.2 million in 2022 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2025: Accumulated Expenses soared 553.2% in 2022, then plunged 87.8% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $10.0 million in 2022, then changed by 0.0% to $10.0 million in 2023, then increased by 24.02% to $12.4 million in 2024, then slumped by 59.98% to $5.0 million in 2025, then sank by 75.46% to $1.2 million in 2026.
• Business Quant data shows LONA's Accumulated Expenses at $1.2 million in Q1 2026, $5.0 million in Q4 2025, and $2.1 million in Q3 2025.